TCA Venture Group highlights for 2025 include four exits, led by 44x return from ParentSquare, investment in 43 companies, and successful annual chapter funds that add diversification and capital
Read MoreCommercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
Commercial Launch Announcement Marks a New Chapter for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) — FDA-Approved Preservative-Free Ketamine Now Being Sold, 17-Person National Sales Team Activated, Market Relationships Cover Approximately 80% of U.S. Ke
Read MoreOriginBio Showcases Microencapsulated Ingredients and Liposomal Technologies at SupplySide Global 2026
XI'AN, China - -- Xi'an OriginBio Technology Co., Ltd. successfully participated in SupplySide Global 2026, held October 28–30 in Las Vegas, Nevada, USA. At Booth #7952, OriginBio presented its microencapsulated ingredient portfolio and liposomal...
Read MoreApplied Courage and Its Impact on Investing: Verb Presents Features Tyler Shultz
SILICON VALLEY, CA, Calif. - -- "Courage," according to the Merriam-Webster Dictionary, is defined as the "mental or moral strength to venture, persevere, and withstand danger, fear, or difficulty." Verb Presents™ is honored to welcome Tyler Shultz as...
Read MoreNew Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
Genprex, Inc. (N A S D A Q: GNPX) Provides New Clinical Patient Analysis Uncovers Promising TUSC2-Associated Biological Activity Involving Mitochondrial Function, Cellular Repair, Autophagy and Protein Quality Control. Combined With the Roche Diagnostics
Read MoreInnuScience and Peerapat to Begin Local Bottling of Biotechnology Cleaning Solutions in Thailand
Canadian biotechnology company InnuScience and Thai partner Peerapat Technology plan to start local bottling in January 2027.
Read MoreNew TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
Strategic Roche Diagnostics Partnership, New Biomarker Findings and Expanding Clinical Research Could Help Transform Patient Selection for Non-Small Cell Lung Cancer Treatment, While Genprex, Inc. (N A S D A Q: GNPX) Advances Additional Opportunities in S
Read MoreFDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Also Received an $11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression
Read MoreAbstract Reports Curtana's CT-179 Extends Survival as a Single Agent in a Patient-Derived Model of Diffuse Midline Glioma
Preclinical study of the first-in-class, brain-penetrant OLIG2 inhibitor will be presented at the 31st Annual Meeting of the Society for Neuro-Oncology
Read MoreCELLKEY AI Officially Launches Omics Marketplace 'OmicsPharm'
CELLKEY AI Officially Launches Omics Marketplace 'OmicsPharm'
Read MoreNatural Field Wraps Up SupplySide Global 2026, with Strong Interest in Liposomal Ingredients & Customized Solutions
At Booth 6511B, Natural Field connected with international buyers and manufacturers, with discussions spanning liposomal ingredients, sports nutrition, botanical extracts, and customized formulation solutions.
Read MoreMajor FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
A Landmark October 30th FDA Approval, Commercial Manufacturing Readiness, Two-Year Stability Results, and an $11.25 Million DARPA Research Contract Put NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) at an Important Turning Point in Its Growth
Read MoreNew Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
Roche Diagnostics $RHHBY Collaboration, Promising REQORSA® Biomarker Research, and Expanding Gene Therapy Programs Put Genprex $GNPX in the Spotlight
Read MoreExpanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
$SNNC acquires Majority Stake in New Joint Venture With Doc-Rx Opens the Door to Telehealth, U.S.-Made Peptides and an Ambitious Wellness Clinic Expansion Strategy
Read MorePreprint Reports Curtana's CT-179 Enhances Radiotherapy in an MGMT-Unmethylated Glioblastoma Model and Extends Survival as a Single Agent
Foundational preclinical study of the first-in-class, brain-penetrant OLIG2 inhibitor supports evaluating CT-179 with standard-of-care therapy, including in MGMT-unmethylated glioblastoma, where temozolomide adds little
Read MoreVITAL CORE LAB Releases Technical Standards and Purity Verification Guidelines for Research Peptides
Comprehensive HPLC and ESI-MS purity verification parameters established to support scientific integrity in laboratory research.
Read MoreNor-Tech Announces AI ProServer with NVIDIA H200 and L40S GPUs
MINNEAPOLIS - -- Nor-Tech, a leading integrator of high-performance computing (HPC) and AI solutions, just announced its AI ProServer, available with NVIDIA H200 or L40S GPUs. Engineered for demanding artificial intelligence workloads, the AI ProServer...
Read MoreNatural Field Showcases Nutrition and Sports Nutrition Ingredients at SupplySide West
XI'AN, China - -- Booth 6511B will feature sports nutrition ingredients, botanical extracts, and liposomal ingredients for supplement brands and manufacturers. Natural Field, a B2B supplier of nutraceutical raw material powders, will exhibit at...
Read MorePeptideSuppliers.tech Explains How It Scores 400+ Peptide Manufacturers and Suppliers
Seven months after launch, the B2B peptide directory explains why it was built, how its confidence scores work, and what it plans next.
Read MoreCommercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
NRXP Reports Three Successfully Manufactured Commercial Lots, Two-Year Stability Data, and Commercially Releasable Supply Pending FDA Approval — While an $11.18 Million DARPA Contract Expands the Company's Research Opportunities
Read More